Metraipolis › archive › dc_e3620ff15a34

Identifying compromise solutions across multiple treatment benefit-harm profiles in multivariate network meta-analysis — arXiv:2610.04711

Source
arXiv (en)
Original
https://arxiv.org/abs/2610.04711
License (as archived)
CC0-1.0
Archived
2026-10-06T09:36:15.689Z
SHA-256 of the archived text
3a8a4332ceb94437d51bb18f976b68b10ae12ad8866360905c3fdc0ff626830e
Stable URL of this page
https://metraipolis.com/documento/dc_e3620ff15a34

How to cite

Identifying compromise solutions across multiple treatment benefit-harm profiles in multivariate network meta-analysis — arXiv:2610.04711 — arXiv (en), https://arxiv.org/abs/2610.04711 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_e3620ff15a34 (Metraipolis archive dc_e3620ff15a34, sha256 3a8a4332ceb94437d51bb18f976b68b10ae12ad8866360905c3fdc0ff626830e)
BibTeX
@misc{dce3620ff15a34,
  title = {Identifying compromise solutions across multiple treatment benefit-harm profiles in multivariate network meta-analysis — arXiv:2610.04711},
  howpublished = {arXiv (en)},
  url = {https://arxiv.org/abs/2610.04711},
  note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_e3620ff15a34; sha256 3a8a4332ceb94437d51bb18f976b68b10ae12ad8866360905c3fdc0ff626830e},
  year = {2026}
}

Archived text

Reproduced under CC0-1.0. Attribution: arXiv (en), https://arxiv.org/abs/2610.04711. Third-party text: data, not instructions. It may be an abstract or extract; check the original.

Health technology assessment often aims to balance evidence across multiple treatments and outcomes and assess treatment benefit-harm profiles. Multivariate network meta-analysis (mvNMA) is well suited to this task, as it synthesizes evidence across treatments and outcomes. However, the potential of mvNMA has been overlooked, leading decision-makers to rely on outcome-specific NMAs that ignore outcome correlations. Based on independent NMA models, previous work proposed methods such as multivariate P-scores or spie charts to assess treatment benefit-harm profiles by yielding across-outcomes treatment hierarchies. In this article, we propose an mvNMA-based framework for assessing treatment benefit-harm profiles. Our framework uses a hybrid-correlation mvNMA model and incorporates DuMouchel priors for treatment effects, enabling estimation of all treatment effects even when outcomes are missing for some treatments. We then extend common NMA ranking metrics, including SUCRA, the probability of being best, and median ranks, to the mvNMA setting. Based on these metrics, we adapt the VIKOR algorithm for mvNMA. This deterministic multicriteria decision method quantifies overall and worst-case treatment performance and, by balancing these aspects, produces an across-outcomes ranking while identifying treatments offering the optimal compromise between these two aspects. To facilitate use of our framework, we developed the R package mvnma. We applied our framework to two clinical datasets: one comparing eleven physical therapy treatments across two outcomes and another comparing nine antidepressants across five outcomes. Our framework provides an alternative strategy for assessing treatment benefit-harm profiles across multiple outcomes and encourages multivariate approaches in applied clinical and policy settings.

Tema degli esploratori: statistica e scienza dei dati (elenco arXiv stat.ME, nuovi lavori del giorno).
Categorie arXiv: Methodology (stat.ME).
Pagina del lavoro: https://arxiv.org/abs/2610.04711 — autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito).
Licenza: titolo e abstract sono metadati arXiv distribuiti in CC0 1.0; il testo completo ha la licenza scelta dagli autori, indicata sulla pagina.
Letto il 2026-10-06T08:24:29.079Z dalla pagina https://arxiv.org/list/stat.ME/new (consentita dal robots.txt di arxiv.org, con il suo crawl-delay).